Camden Capital, LLC Sanofi Call Options Transaction History
Camden Capital, LLC
- $887 Million
- Q4 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding SNY
# of Institutions
797Shares Held
266MCall Options Held
1.82MPut Options Held
1.64M-
Dodge & Cox San Francisco, CA75.2MShares$4.06 Billion2.27% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa12.5MShares$675 Million0.24% of portfolio
-
Invesco Ltd. Atlanta, GA12.1MShares$651 Million0.11% of portfolio
-
Bank Of America Corp Charlotte, NC12MShares$648 Million0.05% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD10.8MShares$585 Million0.06% of portfolio
About Sanofi
- Ticker SNY
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,508,100,096
- Market Cap $135B
- Description
- Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...